Cisb Bennet Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -7.26%
- Ebitda -7.26%
- Net Worth -2.35%
- Total Assets -0.15%
About Cisb Bennet Pharmaceuticals
Cisb Bennet Pharmaceuticals Private Limited (CBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 January 2019 (Six years 22 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Pimple and Sidhant Pimple serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2019PTC320012
-
Company No.
320012
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jan 2019
-
Date of AGM
22 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cisb Bennet Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Pimple
|
Director | 22-Jan-2019 | Current |
|
Sidhant Pimple
|
Director | 01-Oct-2024 | Current |
Financial Performance of Cisb Bennet Pharmaceuticals.
Cisb Bennet Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.26% decrease in profit. The company's net worth dipped by a decrease of 2.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cisb Bennet Pharmaceuticals?
In 2023, Cisb Bennet Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Indo-American Chamber Of CommerceKrishna Pimple is a mutual person
-
Cisb Management Services Private LimitedSidhant Pimple is a mutual person
-
Atlantic Winds Infrastructures Private Limited
Sidhant Pimple is a mutual person
-
Golden Touch Facility Management LlpKrishna Pimple is a mutual person
-
Rasheshwar Realty Llp
Krishna Pimple is a mutual person
-
Cisb Infraprojects Llp
Krishna Pimple is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cisb Bennet Pharmaceuticals?
Unlock and access historical data on people associated with Cisb Bennet Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cisb Bennet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cisb Bennet Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
